Advent Bio's Validation Transformation:
From Paper-Driven CSV to 100% Paperless GxP Compliance with GoVal
With more than 35 years serving the life sciences community with high-quality biochemicals and research reagents, Advent Bio partnered with GoVal to modernise its validation processes — achieving full digital compliance, eliminating manual documentation risk, and gaining the audit readiness its global customer base demands.
[ THE CHALLENGE ]
The Burden of Paper-Based Validation in a Quality-Critical Supply Chain
As a trusted supplier of biochemicals and research reagents to pharmaceutical manufacturers, biotech companies, and research institutions worldwide, Advent Bio operates in a quality landscape where data integrity is not just a regulatory requirement — it is the foundation of customer confidence. Yet for years, the company's computer system validation programme ran on paper-based protocols, manual approval chains, and physical document binders.
The limitations of this approach were becoming increasingly visible. Advent Bio needed a solution to:
- Eliminate GDP and data integrity risks embedded in handwritten records and paper-based approvals.
- Accelerate validation cycle times so that new and updated laboratory and quality systems could be deployed faster without compromising compliance.
- Establish a defensible audit trail aligned with 21 CFR Part 11 and EU GMP Annex 11 requirements across its full validated-system inventory.
- Reduce manual reporting burden on QA and validation teams compiling RTMs, VSRs, and deviations from disconnected paper sources.
- Create a single source of truth for all validation documentation accessible to quality leadership and auditors without retrieval delay.
[ THE SOLUTION ]
GoVal's End-to-End Validation Lifecycle Management System
Advent Bio selected GoVal's Validation Lifecycle Management System (VLMS) to replace its paper-driven CSV programme with a fully digital, workflow-controlled environment. GoVal provided a pre-configured, 21 CFR Part 11-compliant platform tailored to the validation scope of a life sciences reagent and biochemical operation — enabling rapid deployment without a blank-canvas implementation effort.
21 CFR Part 11 & Annex 11 Compliance from Day One
GoVal ships pre-validated with full vendor IQ/OQ documentation, placing Advent Bio in a compliant electronic records environment immediately — no parallel paper system required.
Automated RTM & Validation Summary Reports
GoVal generates live Traceability Matrices and Validation Summary Reports at the click of a button — eliminating the 3–4 days of manual compilation previously required per validation project.
Centralised, Always-On Audit Readiness
Every validation record — URS, FRA, IQ/OQ/PQ protocols, deviations, and approval signatures — is stored in a searchable digital repository, enabling inspection response in hours rather than days.
[ THE OUTCOME ]
A Compliant, Efficient, and Future-Ready Validation Programme
- Zero Paper, Zero GDP Risk: GoVal eliminated Advent Bio's dependency on printed protocols, handwritten test entries, and physical approval routing — removing the entire class of Good Documentation Practice errors that paper-based validation inherits.
- Accelerated Validation Cycles: Automated workflows, electronic signatures, and pre-built templates reduced Advent Bio's per-project validation timeline significantly — releasing QA and validation resource for higher-value quality activities.
- ALCOA+ Data Integrity Built In: Every action on the GoVal platform is captured in an immutable, timestamped audit trail. Advent Bio's validation records now meet ALCOA+ principles natively, without reliance on individual procedural discipline.
- Inspection-Ready in Minutes: Regulatory auditors and customer quality teams can now access Advent Bio's complete validation record set through the GoVal dashboard — a process that previously required days of manual document retrieval.
- Standardised Practices Across Systems: GoVal's centralised template library and controlled workflow engine enforce a consistent validation methodology across all of Advent Bio's GxP-critical systems, from LIMS and chromatography software to QMS and ERP platforms.
- Scalable Foundation for Growth: As Advent Bio introduces new products, platforms, and laboratory systems, GoVal's phased deployment model ensures each new validated system is onboarded quickly using methodology and templates already proven in production.
Frequently Asked Questions
Questions about Advent Bio's paperless validation journey with GoVal.
Supplier GxP compliance is increasingly scrutinised — regulated pharmaceutical and biotech customers now routinely audit their critical reagent and biochemical suppliers for data integrity and validation practices. GoVal gives Advent Bio the documented, auditable validation programme that quality-conscious customers need to qualify Advent Bio as a compliant supplier. The platform's immutable audit trail and inspection-ready dashboards mean Advent Bio can respond to customer quality questionnaires and on-site audits confidently, without manual record retrieval delays.
GoVal's transition methodology does not require the digitisation of historical paper records — a practical decision that eliminates both the compliance risk and resource burden of retroactive migration. Legacy paper binders remain as compliant evidence for previously validated systems. GoVal is introduced as a new validated system under your existing change control framework, and all new validation activity runs digitally from that point forward. Organisations consistently find that 100% paperless status for new and re-validated projects is achievable within a single deployment cycle, regardless of how long paper records have been accumulated.
GoVal's validation framework is designed for multi-jurisdictional operation. The platform accommodates 21 CFR Part 11 (FDA), EU GMP Annex 11 (EMA/MHRA), and GAMP 5 methodology simultaneously — without requiring separate documentation sets for each market. Advent Bio can validate a single system once and produce compliant evidence for US, EU, and UK regulatory contexts from the same GoVal project. This is a material advantage for a company whose customers span multiple regulatory jurisdictions.
GoVal covers the complete GxP-critical system inventory relevant to a life sciences reagent and biochemical operation — not just manufacturing systems. This includes Laboratory Information Management Systems (LIMS), chromatography data systems, spectroscopy software, quality management platforms, ERP modules used in batch and inventory control, and temperature monitoring systems for cold-chain storage. GoVal's risk-based scoping tool assesses each system's GxP impact and determines the appropriate validation depth, ensuring effort is proportionate to risk rather than applied uniformly across all systems.
GoVal's built-in deviation and CAPA management captures test failures in real time, automatically linking them to the relevant test case, risk assessment, and validation project. QA reviewers are notified immediately via the workflow engine, and deviation resolution is tracked through to closure with a full audit trail — eliminating the disconnected spreadsheet tracking and manual CAPA logs that create gaps in paper-based validation programmes. Every deviation and its resolution is available in the validation project record, ready for inspector review without additional compilation.
If your inspection or customer audit is more than 6 weeks away, GoVal can be deployed and running live validation projects before the review date. Because GoVal ships pre-validated with vendor IQ/OQ documentation, Advent Bio is operating in a 21 CFR Part 11-compliant environment from the first week of use — with no additional validation effort required to deploy the platform itself. For organisations with imminent quality reviews, GoVal's centralised dashboard and instant record retrieval provide significant confidence-building value even before full paperless migration is complete.